The reported statements, read against the company's own industry.
Financials view
Market Capitalization
867.31MBRL
186.29M · vs all stocks (USD)
Updated Nov 17, 2026
Revenue (TTM)
4.99BBRL
1.06B · vs all stocks (USD)
Updated Nov 17, 2026
Profit Margin
-84.77%
vs Medical Care Facilities peers
Updated Nov 17, 2026
Beta
1.21x
vs all stocks
Updated Nov 17, 2026
52-Week Change
-56.98%
vs all stocks
Updated Nov 17, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Nov 17, 2026
Market Capitalization
867.31MBRL
186.29M · vs all stocks (USD)
Updated Nov 17, 2026
Enterprise Value
4.71BBRL
954.51M · vs all stocks (USD)
Updated Nov 17, 2026
Forward P/E
9.78x
vs Medical Care Facilities peers
Updated Nov 17, 2026
Price to Sales (TTM)
0.1738x
vs Medical Care Facilities peers
Updated Nov 17, 2026
Price to Book (MRQ)
51.33x
vs Medical Care Facilities peers
Updated Nov 17, 2026
Enterprise to Revenue
0.9440x
vs Medical Care Facilities peers
Updated Nov 17, 2026
Enterprise to EBITDA
-2.51x
vs Medical Care Facilities peers
Updated Nov 17, 2026
Gross Margin
21.89%
vs Medical Care Facilities peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 27.31%.Updated Nov 17, 2026
Profit Margin
-84.77%
vs Medical Care Facilities peers
Updated Nov 17, 2026
Operating Margin
-40.88%
vs Medical Care Facilities peers
Updated Nov 17, 2026
Return on Assets (TTM)
-15.09%
vs Medical Care Facilities peers
Updated Nov 17, 2026
Return on Equity (TTM)
-273.51%
vs Medical Care Facilities peers
Updated Nov 17, 2026
Revenue (TTM)
4.99BBRL
1.06B · vs all stocks (USD)
Updated Nov 17, 2026
Revenue per Share (TTM)
5.74BRLUpdated Nov 17, 2026
Quarterly Revenue Growth
-28.50%
vs Medical Care Facilities peers
Updated Nov 17, 2026
Gross Profit (TTM)
1.36BBRL
307.20M · vs all stocks (USD)
Updated Nov 17, 2026
EBITDA (TTM)
-1.87BBRL
-296.61M · vs all stocks (USD)
Updated Nov 17, 2026
Net Income (TTM)
-4.23BBRL
-749.98M · vs all stocks (USD)
Updated Nov 17, 2026
Quarterly Earnings Growth (YoY)
-28.45%
vs Medical Care Facilities peers
Updated Nov 17, 2026
Operating Cash Flow (TTM)
309.59MBRL
-50.92M · vs all stocks (USD)
Updated Nov 17, 2026
Levered Free Cash Flow (TTM)
-676.82MBRL
-130.87M · vs all stocks (USD)
Updated Nov 17, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Nov 17, 2026
Trailing Annual Dividend Rate
0.00BRLUpdated Nov 17, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Nov 17, 2026
Payout Ratio
0.00%
vs Medical Care Facilities peers
Updated Nov 17, 2026
Minority Interest (Equity)
161.48MBRLFY2025 · Dec 31, 2025
Revenue
5.74BBRLFY2025 · Dec 31, 2025
Cost of Goods Sold
3.95BBRLFY2025 · Dec 31, 2025
Gross Profit
1.79BBRLFY2025 · Dec 31, 2025
Operating Income
-2.47BBRL
-481.54M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-3.16BBRLFY2025 · Dec 31, 2025
Income Tax Expense
508.46MBRLFY2025 · Dec 31, 2025
Net Income
-3.67BBRLFY2025 · Dec 31, 2025
EBIT
-2.53BBRLFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-2.15BBRLFY2025 · Dec 31, 2025
Selling, General & Administrative
1.36BBRLFY2025 · Dec 31, 2025
Other Operating Expenses
2.89BBRLFY2025 · Dec 31, 2025
Non-operating Interest Income
13.12MBRLFY2025 · Dec 31, 2025
Non-operating Interest Expense
636.27MBRLFY2025 · Dec 31, 2025
EPS (Basic)
-4.18BRLFY2025 · Dec 31, 2025
EPS (Diluted)
-4.18BRLFY2025 · Dec 31, 2025
Basic Shares Outstanding
866.52MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
866.52MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-3.67BBRLFY2025 · Dec 31, 2025
Minority Interests (P&L)
47.32MBRLFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00BRLFY2025 · Dec 31, 2025
Operating Cash Flow
-2.06BBRLFY2025 · Dec 31, 2025
Free Cash Flow
-2.23BBRLFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
509.55MBRLFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-3.67BBRLFY2025 · Dec 31, 2025
Stock-based Compensation
22.18MBRLFY2025 · Dec 31, 2025
Other Non-cash Items
1.81BBRLFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-319.26MBRLFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
103.08MBRLFY2025 · Dec 31, 2025
Capital Expenditures
-168.12MBRLFY2025 · Dec 31, 2025
Net Acquisitions
-76.74MBRLFY2025 · Dec 31, 2025
Other Investing Activity
5.76MBRLFY2025 · Dec 31, 2025
Net Investing Cash Flow
-239.09MBRLFY2025 · Dec 31, 2025
Long-term Debt Issuance
310.12MBRLFY2025 · Dec 31, 2025
Long-term Debt Payments
-735.06MBRLFY2025 · Dec 31, 2025
Common Stock Repurchase
-3.69MBRLFY2025 · Dec 31, 2025
Common Dividends Paid
-36.78MBRLFY2025 · Dec 31, 2025
Other Financing Charges
-26.60MBRLFY2025 · Dec 31, 2025
Net Financing Cash Flow
-490.92MBRLFY2025 · Dec 31, 2025
Shares Outstanding
1.12BSharesUpdated Nov 17, 2026
Float Shares
568.97MSharesUpdated Nov 17, 2026
% Held by Insiders
13.61%
vs all stocks
Updated Nov 17, 2026
% Held by Institutions
65.07%
vs all stocks
Updated Nov 17, 2026
Total Cash (MRQ)
113.46MBRL
21.92M · vs all stocks (USD)
Updated Nov 17, 2026
Total Cash per Share (MRQ)
0.1010BRLUpdated Nov 17, 2026
Total Debt (MRQ)
3.88BBRL
749.74M · vs all stocks (USD)
Updated Nov 17, 2026
Total Debt to Equity (MRQ)
39.49x
vs Medical Care Facilities peers
Updated Nov 17, 2026
Current Ratio (MRQ)
0.4430x
vs Medical Care Facilities peers
Updated Nov 17, 2026
Book Value per Share (MRQ)
0.0150BRLUpdated Nov 17, 2026
Total Assets
7.13BBRL
1.39B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.90BBRLFY2025 · Dec 31, 2025
Total Liabilities
6.07BBRLFY2025 · Dec 31, 2025
Total Non-current Assets
4.23BBRLFY2025 · Dec 31, 2025
Total Non-current Liabilities
866.17MBRLFY2025 · Dec 31, 2025
Total Current Liabilities
5.20BBRLFY2025 · Dec 31, 2025
Cash
35.90MBRLFY2025 · Dec 31, 2025
Cash Equivalents
473.64MBRLFY2025 · Dec 31, 2025
Cash & Cash Equivalents
509.55MBRLFY2025 · Dec 31, 2025
Other Short-term Investments
736.00KBRLFY2025 · Dec 31, 2025
Accounts Receivable
2.03BBRLFY2025 · Dec 31, 2025
Inventory
185.48MBRLFY2025 · Dec 31, 2025
Accounts Payable
1.10BBRLFY2025 · Dec 31, 2025
Short-term Debt
3.22BBRLFY2025 · Dec 31, 2025
Other Current Liabilities
157.72MBRLFY2025 · Dec 31, 2025
Long-term Debt
574.32MBRLFY2025 · Dec 31, 2025
Other Non-current Liabilities
67.53MBRLFY2025 · Dec 31, 2025
Common Stock (Book)
4.56BBRLFY2025 · Dec 31, 2025
Retained Earnings
-4.33BBRLFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.06BBRL
207.41M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
87.57MBRLFY2025 · Dec 31, 2025
52-Week Low
0.5300BRLUpdated Nov 17, 2026
52-Week High
3.07BRLUpdated Nov 17, 2026
52-Week Change
-56.98%
vs all stocks
Updated Nov 17, 2026
Beta
1.21x
vs all stocks
Updated Nov 17, 2026
50-Day MA
1.02BRLUpdated Nov 17, 2026
200-Day MA
1.35BRLUpdated Nov 17, 2026
Avg 10-Day Volume
5.28MSharesUpdated Nov 17, 2026
Avg 30-Day Volume
6.72MSharesUpdated Nov 17, 2026
Diluted EPS (TTM)
-5.13BRLUpdated Nov 17, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -24.3%, lower than 95% of its Medical Care Facilities peers (median 11.3%)Significant